Experimental Substantiation of a New Method of Treatment of Cerebral Ischemia in Rats

Abstract


Currently installed neuroprotective properties of erythropoietin(EP)associated with anti-apoptotic and antihypoxic action. Along with this, it is known that the influence of the laser radiation in the middle infrared range increases microcirculation, increase the functional activity of endothelial cells that leads to activation of neoangiogenesis. The purpose of the study To develop a method of treating ischemia in the cerebral cortex(GM) on the basis of studies of behavioral and vascular reactions, pathological changes in animals with the introduction of recombinant EP and the influence of the laser radiation. Materials and methods An experiment was conducted at 130 outbred adult rats of both sexes weighing 220-250g. Animals are divided into 5 series of experiments: 1-series - modeling cerebral cortex GM (n=30). 2-I series - ischemia crust GM and the introduction of intraperitoneal recombinant EP (n=30). 3 series - ischemia crust GM and cutaneous laser irradiation region of the ischemic lesion(n=30. 4-series - ischemia crust GM treated with EP in conjunction with cutaneous laser irradiation(n=30). 5 series(control) rats with craniotomy, but without modeling the cerebral cortex GM (n=10). Animals were taken from experiment 7, 14, 30 days. Results and their discussion It is shown that the introduction of recombinant EP in combination with laser radiation in cerebral cortex GM increases in the early stages of the experiment, the tolerance of neurons to hypoxic damage, improves microcirculation. This is probably due to anti-apoptotic and antihypoxic action EP, and increased functional activity of endothelial cells under laser irradiation. Сonclusion 1. The combined effect of recombinant EP and laser radiation significantly reduces the area of the heart, enhances proliferation of endothelial cells with the development of new vasculature in the early stages of the experiments. 2. These structural changes are accompanied by an earlier regression of neurological disorders and improving behavioral reactions in experimental animals

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Author for correspondence.
Email: author@vestnik-surgery.com

Russian Federation – MD, Prof., Vice Director, State Budget Institution of Health Center to provide specialized medical care, "Chelyabinsk State Institute of Laser Surgery"

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: author@vestnik-surgery.com

Russian Federation - MD, Prof., Director, State Budget Institution of Health Center to provide specialized medical care, "Chelyabinsk State Institute of Laser Surgery";

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: ak_n@rambler.ru

Russian Federation Chairman of the Department of Neurosurgery, State Budget Institution of Health Regional Clinical Hospital №3

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: author@vestnik-surgery.com

Russian Federation MD, Prof., worked at the State Budget Institution of Health Center to provide specialized medical care, "Chelyabinsk State Institute of Laser Surgery"

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: author@vestnik-surgery.com

Russian Federation Ph.D., Head of the Department of the Scientific Research, State Budget Institution of Health Center to provide specialized medical care, "Chelyabinsk State Institute of Laser Surgery"

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: author@vestnik-surgery.com

Russian Federation Neurosurgeon, Department of Neurosurgery, State Budget Institution of Health Regional Clinical Hospital №3;

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: author@vestnik-surgery.com

Russian Federation Ph.D., Senior Scientific Researcher, Division of Engineering and Physics, State Budget Institution of Health Center to provide specialized medical care, "Chelyabinsk State Institute of Laser Surgery";

Cheliabinsk State Institute of Laser Surgery, 287 Pobedy Ave., Cheliabinsk, 454021, Russian Federation

Email: author@vestnik-surgery.com

Russian Federation – Ph.D., Senior Scientific Researcher, Division of Engineering and Physics, State Budget Institution of Health Center to provide specialized medical care, "Chelyabinsk State Institute of Laser Surgery"

  1. Volchegorskij I.A., Dolgushin I.I., Kolesnikov O.L., Cejlikman V.EH. EHksperimental'noe modelirovanie i laboratornaya ocenka adaptivnyh reakcij organizma [Experimental modeling and laboratory evaluation of adaptive reactions of the organism.] CHelyabinsk: Izdatel'stvo CHGPU, 2000; 25-33.
  2. Golovneva E.S. O roli tuchnyh kletok v stimulyacii processa neoangiogeneza v otvet na vozdejstvie vysokointensivnogo lazernogo izlucheniya [On the role of fat cells to stimulate the process of neoangiogenesis in response to high-intensity laser radiation.] Lazernaya medicina, 2001; 5: 29-32.
  3. Kozel' A.I., Popov G.K., Giniatullin R.U., Astahova L.V., Kuz'min A.N., Ignat'eva E.N., Kravchenko T.G. Sposob lecheniya ishemii golovnogo mozga v ehksperimente: Patent RF na izobretenie № 2495688 ot 20.10.2013 [A method of treating cerebral ischemia in experiment: RF Patent for the invention № 2495688 from 20.10.2013.]
  4. Mchedlishvili G.I. Modelirovanie zabolevanij central'noj nervnoj sistemy. Modelirovanie zabolevanij [Modeling diseases of the Central nervous system. Modeling diseases.] Pod redakciej S.V. Andreeva. Moskva: Medicina, 1973; 79-81.5.
  5. Onishchenko L.S., Gajkova O.N., YAnishevskij S.N. Izmeneniya v ochage ehksperimental'nogo ishemicheskogo insul'ta pod vozdejstviem nejroprotektivnyh preparatov [Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs.] Morfologiya, 2006; 6: 40-46.
  6. Celik M., Gokmen N., Erbayraktar S. et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. [Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.] Proc. Natl. Acad. Sci. USA, 2002; 99: 2258-2263.
  7. Masuda S., Nagan M., Takahata K. et al. Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. [Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells.] J. Biol. Chem., 1993; 268: 11208-11216.
  8. Santhanam A.V., Katusic Z.S. Erythropoietin and cerebral vascular protection: role of nitric oxide. [ Erythropoietin and cerebral vascular protection: role of nitric oxide.] Acta Pharmacol Sin., 2006; 27: 1389-1394.
  9. Siren A. L., Fratelli M., Brines M. et al. Erythropietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. [Erythropietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.] Proc. Natl. Acad. Sci. USA, 2001; 98: 4044-4049.
  10. Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, Valable S, Ghezzi P, Quackenbush J, Brines M, Cerami A, Probert L. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. [TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.] PNAS, 2008; 105: 16: 6185-6190.
  11. Wang L., Zhang Z., Wang Y., Zhang R., Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. [Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.] Stroke, 2004; 35: 1732-1737.

Views

Abstract - 65

PDF (Russian) - 62

PlumX

Dimensions


Copyright (c) 2014 ., ., ., ., ., ., ., .

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies